John David Finley - Jan 3, 2024 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
CEO, CFO, Director, Director
Signature
/s/ JD Finley
Stock symbol
PALI
Transactions as of
Jan 3, 2024
Transactions value $
$0
Form type
4
Date filed
1/5/2024, 04:00 PM
Previous filing
Dec 19, 2023
Next filing
Feb 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PALI Common Stock, par value $0.01 Options Exercise $0 +1.31K +2.07% $0.00 64.6K Jan 3, 2024 Direct F1
holding PALI Common Stock, par value $0.01 777 Jan 3, 2024 By FCW Investments, LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Options Exercise -1.31K -100% 0 Jan 3, 2024 Common Stock 1.31K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units.
F2 Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity.
F3 This restricted stock unit was granted on January 3, 2023 and 1,309 restricted stock units subject to the award vested on January 3, 2024. There are no additional restricted stock units underlying this grant.
F4 Each restricted stock unit represents the right to receive, at settlement, one share of common stock.